Arcofemi Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 0.50 M
as on 17-07-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 67.30 Cr
as on 17-07-2024
- Revenue 20.09%
(FY 2023)
- Profit -3.49%
(FY 2023)
- Ebitda -11.04%
(FY 2023)
- Net Worth 49.01%
(FY 2023)
- Total Assets -40.30%
(FY 2023)
About Arcofemi Healthcare
The Company is engaged in the Internet Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹67.30 Cr.
Rameshwar Tayal, Radhanath Pattanayak, and Rishabh Saraf serve as directors at the Company.
- CIN/LLPIN
U24240DL2011PTC216307
- Company No.
216307
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Mar 2011
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Arcofemi Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rameshwar Tayal  | Director | 27-Jul-2018 | Current |
| Radhanath Pattanayak | Director | 22-Mar-2011 | Current |
| Rishabh Saraf | Director | 21-Nov-2013 | Current |
Financial Performance and Corporate Structure Insights of Arcofemi Healthcare.
Arcofemi Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.09% increase. The company also saw a slight decrease in profitability, with a 3.49% decrease in profit. The company's net worth Soared by an impressive increase of 49.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arcofemi Healthcare?
In 2023, Arcofemi Healthcare had a promoter holding of 98.00% and a public holding of 2.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Advanced Metrics LimitedActive 12 years 11 monthsRameshwar Tayal and Rishabh Saraf are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Jan 2023 | ₹12.30 Cr | Open |
Others Creation Date: 22 Dec 2020 | ₹30.00 Cr | Open |
Others Creation Date: 25 Oct 2019 | ₹25.00 Cr | Open |
How Many Employees Work at Arcofemi Healthcare?
Unlock and access historical data on people associated with Arcofemi Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arcofemi Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arcofemi Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
